醫用包裝薄膜：市場佔有率分析、行業趨勢和統計、成長預測（2025-2030 年）

Medical Packaging Films - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

出版日期: 2025年01月05日 | 出版商:

Mordor Intelligence | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 2025 年醫療包裝薄膜市場規模為 83.1 億美元，到 2030 年將達到 107.6 億美元，預測期內（2025-2030 年）的複合年成長率為 5.31%。

此市場規模反映了醫療包裝產業各個應用領域的包裝膜產品的價值，並按實際計算。包裝薄膜由聚乙烯、聚丙烯、雙向拉伸聚對苯二甲酸乙二醇酯、聚亞苯醚、聚氯乙烯、EVOH、聚苯乙烯（PS）、尼龍等塑膠材料製成，各種金屬均視為市場研究範圍。

主要亮點

世界各國政府正大力投資醫療和醫藥產品及解決方案，以對抗疫情造成的傷害並防止新冠肺炎疫情復發。例如，根據美國衛生指標與評估研究所（IHME）2021年9月的報告，2019年全球人均醫療支出為1,129美元，預計2050年將增加到1,515美元。創新包裝和積極主動的措施正在成為醫療產業的常態，預計這將推動對醫療包裝薄膜的需求。
該市場是包裝行業中成長最快的領域，在供應鏈安全問題、監管要求不斷變化的以及供需失衡等挑戰中，許多促進因素加速了該市場的成長。在預測期內，由於各市場參與者採取多項舉措來限制塑膠材料的使用，生質塑膠塑膠薄膜的佔有率預計將擴大。然而，由於所研究市場的挑戰性，與塑膠薄膜的其他終端用戶產業相比，這些舉措可能對以永續包裝薄膜取代塑膠薄膜的影響較小，從而維持市場成長。
由於用於治療癌症等慢性疾病的藥物數量的增加，以及對這些藥物的小袋、小藥囊和小包裝的需求不斷增加，預計市場將顯著成長。此外，人口老化和糖尿病發病率預計將為市場擴張提供新的機會。
市場成長面臨的主要挑戰包括原料價格波動、持續的永續性動力（包括用生物分解性材料取代塑膠包裝產品）以及強制在塑膠包裝中使用消費後回收（PCR）塑膠。通常，該行業的原料成本佔銷售額的55-60％。因此，盈利很容易受到原物料價格波動的影響。軟包裝薄膜的主要投入成本是原油衍生性商品，而原油衍生性商品本身就具有波動性。
在持續近一到兩年的新冠疫情期間，包裝薄膜製造商面臨大量問題。封鎖的影響包括供應鏈中斷、勞動力短缺、製造過程中所用原料的短缺、價格波動導致最終產品產量膨脹並超出預算以及運輸問題。

醫用包裝薄膜的市場趨勢

生質塑膠材料和可回收包裝的需求不斷成長，推動了醫療包裝薄膜市場的發展

研究市場正在使用生質塑膠來減少對環境的影響。由於工業中大量使用塑膠，導致廢棄物數量急劇增加。因此，將生物分解性塑膠用於醫療應用有助於保護環境。
醫用袋廣泛應用於醫療應用，特別是在需要大量、低成本包裝時，因為其主要優點包括保護醫療產品、便於運輸和品牌推廣。這些袋子通常用於存放急救箱、藥品和醫療設備。這些小袋還可以用來儲存工具和液體藥物。
此外，包裝薄膜製造商正專注於使用可回收材料創新醫療包裝解決方案，以實現其產品的更高永續性。例如，2021 年 11 月，永續包裝解決方案提供商 Coveris 推出了一系列基於醫療包裝單膜的可回收單 PE 薄膜，品牌為 Flexopeel T 和 Formpeel T。該公司將杜邦公司的未塗層Tyvek 1073B 與 Coveris 公司的基於 PE 樹脂的單結構薄膜結合在一起。
包裝產業對生質塑膠材料的需求不斷成長，推動了市場研究。包裝製造商可以使用生質塑膠來取代聚合物基塑膠。生質塑膠的使用將減輕醫療包裝禁令的影響，而永續性的擔憂預計將導致聚合物樹脂基包裝使用量的下降。據歐洲生物塑膠協會稱，2021年全球軟質包裝用生質塑膠產能為66.5萬噸。
研究市場中的主要企業正在推出新產品，以跟上不斷變化的消費者偏好並保持與市場需求的相關性。例如，加拿大包裝和藥物分配公司 Jones Healthcare Group 於 2021 年 12 月透過永續包裝產品擴展了其藥房的 Qube 和 FlexRx 藥物依從性產品線。該公司推出了由醫學認可的生質塑膠Bio-PET 製成的 Qube Pro、FlexRx One 和 FlexRx Reseal泡殼包裝。

亞太地區可望成為成長最快的市場

由於中階人口不斷成長、可支配收入不斷提高以及中國、印度、印尼和馬來西亞等新興經濟體對醫療保健和藥品的需求不斷增加，亞太地區預計將在接受調查的市場中以最高的成長率擴張。該地區蓬勃發展的藥品生產極大地推動了該地區阻隔膜市場的成長。
亞洲腎臟疾病發生率的不斷上升，迫使人們開發新的治療方法，包括先進的設備來改善治療。由於糖尿病和高血壓發病率的上升，亞洲腎臟疾病的盛行率正在上升。此外，對延長醫療設備和產品的保存期限以及消除細菌和病毒污染的可能性的重視正在推動醫療保健行業對包裝薄膜的需求。
由於醫用包裝薄膜解決方案具有節省成本、永續性和包裝產品安全性等優勢，預計中國和印度等人口眾多的新興國家的醫用包裝薄膜需求將大幅增加。此外，由於強大的工業基礎、對永續包裝解決方案不斷成長的需求以及主要製造商的存在，預計亞太地區將在金額和數量方面引領市場。
植入式設備需求的不斷成長和醫療保健市場的蓬勃發展也推動了醫用包裝薄膜的需求。由於中國和印度等新興市場對植入式設備的需求不斷成長以及公眾意識不斷增強，市場規模不斷擴大。
隨著醫療衛生領域的擴大，中國的醫療設備市場正以驚人的速度成長。這個特定產業是中國成長最快的產業之一。在動態法規的推動下，該產業正以兩位數的速度成長，其中近70%的成長來自醫院。傳統上，中國醫療設備市場以低階耗材、機械治療設備及輔助器具數量較多著稱。傳統上，必要的高階消耗品的採購嚴重依賴進口，因為這些產品不是本地生產的。
目前，高價值、高風險的醫療設備正在向國內轉移生產，可望帶動中國醫用包裝薄膜市場的發展。此外，人口老化也是中國高階醫療設備需求增加的驅動力之一。根據世界衛生組織（WHO）的數據，到2040年，中國60歲以上人口預計將達到28%。預計這一不斷成長的人口將比以前變得更加富裕，並且能夠負擔得起醫療保健服務。

醫用包裝薄膜產業概況

醫用包裝薄膜市場主要參與者如下：霍尼韋爾、3M、安姆科等公司都採用了新產品發布、合資、合作、收購等各種策略來擴大其在該市場的影響力。

2022 年 4 月-負責任包裝解決方案開發和生產的全球領導者 Amcor 宣布將在其藥品包裝產品組合中添加永續的高屏蔽層壓板。新的低碳、可回收包裝選擇在兩個方面實現，滿足行業所需的阻隔性和性能要求，同時支持製藥公司的可回收目標。
2022 年 1 月 - 再生材料產品和阻隔性保護包裝領域的主要企業Klockner Pentaplast 宣布計劃進行一項重大投資，以擴大其在北美的消費後回收 (PCR) PET 生產能力，從而進一步擴大其在消費者健康、醫藥和食品包裝市場的永續創新產品。該公司擁有使用 PCR 材料生產 20% 以上產品的能力。此次擴建將增加一條擠出生產線和兩台熱成型機，總合新 rPET 或 PET 產能達到 15,000 噸。

其他福利：

Excel 格式的市場預測 (ME) 表
3 個月的分析師支持

The market size reflects the value of packaging film products across medical packaging industry applications and is computed in the real term. Packaging films are made from plastic materials, such as polyethylene, polypropylene, biaxially oriented polyethylene terephthalate, polyphenylene ether, polyvinyl chloride, EVOH, polystyrene (PS), nylon, and various metals are considered as per the scope of the market study.

Key Highlights

Governments worldwide are heavily investing in medical and pharmaceutical products and solutions in damage control and the prevention of any potential resurgence of the COVID-19 pandemic. For instance, according to the Institute for Health Metrics and Evaluation (IHME), published in September 2021, the global per capita health expenditure was USD 1,129 in 2019, and it is projected to increase to USD 1,515 by 2050. Innovative packaging and preemptive measures are expected to become the norm in the medical industry, driving the demand for medical packaging films.
The market studied is a burgeoning segment of the packaging sector, with many drivers accelerating the growth amid the challenges in the form of supply chain security woes, changing regulatory demands, and supply and demand imbalances. During the forecast period, bioplastic films are expected to increase their share on account of several initiatives taken by various market entities to curb the use of plastic materials. However, owing to the severe nature of the market studied, these initiatives are likely to have less impact on replacing plastic films with sustainable packaging films compared to other end-user industries of plastic films, thereby sustaining the market growth.
The market is expected to experience significant growth, owing to the increase in therapeutics for chronic illnesses, such as cancer and the increasing demand for pouches, bags, and sachets for therapeutic medicines. Additionally, the aging population and the incidence of diabetes are projected to present new opportunities for market expansion.
Some of the major challenges for the market growth are the volatility of raw material prices, the ongoing drive for sustainability, which includes replacing plastic-based packaging products with biodegradable materials, and mandates of using post-consumer recycled (PCR) plastics in plastic packaging. Usually, raw material costs are attributed to 55-60% of sales in this industry. Therefore, profitability is vulnerable to volatility in raw material prices. The key input cost for flexible packaging film is crude derivatives, which have been inherently volatile.
During the COVID-19 pandemic, packaging film manufacturers were flooded with a pool of issues that lasted long for nearly one or two years. Some of the effects of lockdown included supply chain disruptions, labor shortages, lack of availability of raw materials used in the manufacturing process, fluctuating prices that caused the production of the final product to inflate and go beyond budget, transportation problems, etc.

Medical Packaging Films Market Trends

Increasing Demand for Bioplastic Material and Recyclable Packaging Material Drives the Medical Packaging Films Market

Bioplastics are being used in the market studied to reduce environmental impact. The amount of waste increased dramatically due to the extensive use of plastics in the industry. Thus, using biodegradable plastic in medical applications contributes to environmental protection.
Medical bags are widely used in medical applications, particularly when low-cost packaging in large quantities is required, owing to the primary benefits, such as medical product protection, ease of transportation, and brand promotion. These bags are frequently used to store first aid kits, medications, and medical equipment. Pouches can be used to store tools or liquid medications.
Moreover, packaging film manufacturers are focusing on innovating medical packaging solutions with recyclable materials to achieve greater sustainability in their product offerings. For instance, in November 2021, Coveris, a sustainable packaging solution provider, launched recyclable mono-PE film based on mono films branded Flexopeel T and Formpeel T for medical packaging. The company combined an uncoated Tyvek 1073B from DuPont and a mono-structure film from Coveris, based on PE resins.
The increasing demand for bioplastic material in the packaging segment has been driving the market study, as packaging product producers have alternatives for polymer-based plastic in the form of bioplastic. Using bioplastic reduced the impacts of bans and an anticipated reduction in polymer plastic-based packaging usage in medical packaging, owing to sustainability concerns. According to European Bioplastics, in 2021, the global production capacity of bioplastics for flexible packaging was 665,000 metric tons.
Key players in the market studied are launching new products to cater to changing consumer preferences and stay relevant to market demand. For instance, the Canadian packaging and medication dispenser company Jones Healthcare Group expanded the Qube and FlexRx medication adherence product lines for pharmacies with sustainable packaging products in December 2021. The company launched Qube Pro, FlexRx One, and FlexRx Reseal blister packs made of Bio-PET, a bioplastic that received medical approval.

Asia Pacific is Expected to be the Fastest Growing Market

The Asia Pacific is expected to expand with the highest growth rate in the market studied, majorly due to the increasing middle-class population, disposable incomes, and demand for medical and pharmaceutical products in developing economies such as China, India, Indonesia, and Malaysia. The booming pharmaceutical production in the region is significantly driving the growth of the barrier film market in the region.
The increasing prevalence of kidney disease in Asia necessitated the development of new therapies, including sophisticated devices to improve treatment. The prevalence of kidney disease in Asia is increasing due to increasing rates of diabetes and hypertension. Furthermore, the emphasis on extending the shelf life of medical devices and products and eliminating the possibility of bacterial or viral contamination increased the demand for packaging film in the medical and healthcare industries.
As medical packaging film solutions offer benefits, like cost savings, sustainability, and safety of packaged products, significant growth has been seen for medical packaging films from populated developing countries, such as China and India. Moreover, the Asia-Pacific region is anticipated to lead the market studied in terms of value and volume due to the solid industrial base, increased demand for sustainable packaging solutions, and the presence of key manufacturers in the region.
The demand for medical packaging films is also fueled by the increasing demand for implantable devices and the booming healthcare market. The market expanded due to the escalating demand for implantable devices and increasing public awareness in developing nations like China and India.
Along with the expanding healthcare sector, China's medical device market is increasing at an incredible pace. This specific sector is one of the fastest-increasing sectors in China. The sector is increasing at a double-digit growth rate, driven by dynamic regulations, nearly 70% of which was contributed to by hospital procurement. Traditionally China's medical devices market is well known for large volumes of low-end consumables, mechanotherapy devices, and aids. There has been large dependence on imports for procuring required high-end consumables as they were not traditionally manufactured in the country.
Currently, there has been a shift toward domestically made high-value and high-risk medical devices, which are expected to drive the Chinese medical packaging film market. Moreover, the aging population is one of the driving factors for the increase in demand for high-end Chinese devices. According to the World Health Organization (WHO), the population aged more than 60 years is expected to reach 28% in China by 2040. This increasing demographic, which is increasingly affluent, is expected to be able to spend more on healthcare services than before.

Medical Packaging Films Industry Overview

The Medical Packaging Films Market is fragmented in nature, and the major players such as Honeywell, 3M, Amcor, etc. have used various strategies such as new product launches, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

April 2022 - Amcor, one of the global leaders in developing and producing responsible packaging solutions, announced the addition of sustainable high shield laminates to its pharmaceutical packaging portfolio. The new low carbon, recycle-ready packaging options deliver on two fronts, providing the high barrier and performance requirements needed for the industry while supporting pharmaceutical companies' recyclable objectives.
January 2022 - Klockner Pentaplast, a leading company in recycled content products and high-barrier protective packaging, announced its plans to expand its post-consumer recycled content (PCR) PET capacity in the North America region with a significant investment to further increase its sustainable innovation offering in consumer health and pharmaceutical food packaging markets. The company has the capacity, with more than 20% of its volumes made from PCR material. The expansion is set to add an extrusion line and two thermoformers, providing a total of 15,000 metric tons of new rPET or PET capacity.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

1 INTRODUCTION

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

4.1 Market Overview
4.2 Industry Attractiveness - Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat Of New Entrants
- 4.2.4 Threat of Substitute Products
- 4.2.5 Intensity of Competitive Rivalry
4.3 Industry Value Chain Analysis
4.4 Assessment of the Impact of COVID-19 on the Market

5 MARKET DYNAMICS

5.1 Market Drivers
- 5.1.1 Increasing Demand for Bioplastic and Recyclable Packaging Material
- 5.1.2 Increased Spending on Healthcare Facilities, Primarily Owing to Increase in Chronic Diseases
5.2 Market Restraints
- 5.2.1 Fluctuation in the Prices of Raw Materials

6 MARKET SEGMENTATION

6.1 Material Type
- 6.1.1 Plastic Film
  - 6.1.1.1 PE
  - 6.1.1.2 PP
  - 6.1.1.3 PVC
  - 6.1.1.4 PC
- 6.1.2 Metallic Film
6.2 Application
- 6.2.1 Bags & Pouches
- 6.2.2 Tubes
- 6.2.3 Other Applications
6.3 Geography
- 6.3.1 North America
- 6.3.2 Europe
- 6.3.3 Asia Pacific
- 6.3.4 Latin America
- 6.3.5 Middle East and Africa

7 COMPETITIVE LANDSCAPE

7.1 Company Profiles
- 7.1.1 Honeywell International Inc.
- 7.1.2 3M Company
- 7.1.3 Wipak Oy
- 7.1.4 Amcor Plc
- 7.1.5 DuPont de Nemours, Inc.
- 7.1.6 Renolit Medical
- 7.1.7 PolyCine GmbH
- 7.1.8 Glenroy, Inc.
- 7.1.9 Toray Industries, Inc.
- 7.1.10 Klockner Pentaplast Group
- 7.1.11 Dunmore Corporation
- 7.1.12 Covestro AG